The MHRA approved Lecanemab - shown to slow Alzheimer's cognitive decline - but NICE said the cost and workload of prescribing was too high.
Sofia Lind is the Deputy Editor at Pulse, a leading source of news and information for general practitioners in the UK. With a focus on healthcare and general practice, Sofia covers a wide range of topics including government policies, healthcare challenges, and advancements in medical technology. Her work has also been featured in Healthcare Leader, further establishing her expertise in the field.